Ask the Experts.

Slides:

Advertisements

Similar presentations

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Advertisements

Immunotherapies: Key Considerations in the Identification and Management of irAEs.

Clinical Trials in IBD.

Unraveling Clinical Developments in NASH

Improving Survival in Glioblastoma Multiforme

T-Cell Exhaustion: Can We Overcome It in Cancer?

Advances in Managing Inhibitors in Patients With Hemophilia A

Relapsed/Refractory Follicular Lymphoma Conundrums

Dual Antiretroviral Therapy

Progression After Cancer Immunotherapy in Advanced NSCLC

Chronic Rhinosinusitis

Chronic Rhinosinusitis

Atopic Dermatitis Treatment Landscape

Mid-Year Hemophilia Update

Induction Chemotherapy for Patients With High-Risk or Secondary AML

Determining the Best Treatment Algorithm for Patients With Head and Neck Cancer.

BTK Inhibitors in Relapsed/Refractory Mantle Cell Lymphoma

The Resurgence of Topical Treatments Across a Spectrum of Psoriasis

Aligning Patients and Clinicians: Optimizing Outcomes in Metastatic NSCLC.

Emerging Targeted Agents for Relapsed/Refractory Non-Hodgkin Lymphoma

The Nurse View.

Addressing Disease Burden in Asthma

The Evolving Role of Immunotherapy in NSCLC

Immunotherapy in Pancreatic Cancer: Thinking Outside the Box

Optimizing Management of Advanced Bladder Cancer

Addressing Challenges in Factor VIII Inhibitors in Children With Hemophilia.

The Emerging Role of Immunotherapy in Hodgkin Lymphoma

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Next-Gen Psoriasis Therapies:

Management of CMV in HSCT Recipients

Evaluating Next-Generation BTK Inhibitors

Case Studies in Unresectable Hepatocellular Carcinoma

Hyperhidrosis Is Burdensome!

Gene Therapy: Past, Present, and Future

Emerging Atopic Dermatitis Treatments:

Essential Concepts in the Use of Immunotherapies in Bladder Cancer

Immunotherapy for cSCC

Optimizing Frontline Care for Older Patients With Multiple Myeloma

New Data on Emerging Treatments for Psoriasis

When Is Biologic Therapy Appropriate for HS?

Expert Insights Into the Latest Treatment of Advanced Soft-Tissue Sarcoma.

Personalizing Management in the Care of Patients With Advanced Sarcoma

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States and data.

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Expert Perspectives on the Clinical Use of Immune Reconstitution vs Escalation Therapy for MS.

Developments in the Wet AMD Treatment Landscape

Parkinson Disease Psychosis

Talking With Your Patients About Excessive Sweating

Getting to Grips With the Science of CGRP and Migraine

Advances in Immunotherapy for Peanut Allergy

Immune Checkpoint Inhibitors in Lung Cancer

Guide to Atopic Dermatitis

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Patient Questions and Expert Answers in Psoriasis:

Biomarker Testing: Harnessing All Sides of the Tumor Microenvironment

Optimizing Joint Health in Hemophilia

The Psychiatrist's Role in Tardive Dyskinesia

Patient and Clinician Perspectives on Preventive Therapy for Migraine

This program will include a discussion of off-label treatment and investigational agents not approved by the Food and Drug Administration for use in the.

Novel Concepts in the Management of RCC

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States, and data.

From Adjuvant to Metastatic in Melanoma

The Nurse View: Spotlight on Immune Checkpoint Inhibitors in Advanced Lung Cancer.

The Psychiatrist's Role in Tardive Dyskinesia

Optimizing Outcomes in mRCC: Finding the Balance of Immune Inhibition

This program will include a discussion of off-label treatment or use of investigational agents not approved by the FDA for use in the US, and data that.

Checkpoint Inhibitors in First-Line Advanced NSCLC

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Immune Checkpoint Inhibitors in Lung Cancer

Presentation transcript:

Ask the Experts

This program will include a discussion of off-label treatments and investigational agents not approved by the FDA for use in the US. These data should be considered preliminary until published in a peer-reviewed journal.

EoE Overview

Epidemiology of EoE

Symptoms of EoE Children

Clinical Symptoms of EoE Adolescents and Adults

Diagnosis of EoE Is Challenging

Endoscopic Findings

The PPI Diagnostic Dilemma

The PPI Diagnostic Dilemma (cont)

Treatment Goals

Treatment Options for EoE

PPI Therapy

Steroids for EoE Overview

Swallowed Topical Steroids

Optimal Delivery of Topical Steroids

Budesonide Nebulized vs Viscous Oral Formulations

Budesonide Oral Suspension Phase 2 Trial

Budesonide Orodispersible Tablet Phase 3 Trial

Fluticasone Dissolvable Tablet Phase 1/2A Study

Elemental Diet

Elimination and Allergy-Directed Diets

Step-Up/Step-Down Elimination Diets

Elimination Diet Patient Education

IL-5 Inhibitors

Dupilumab Phase 2 Study

Anti-IL-13 RPC4046 Phase 2 Study

Endoscopic Dilation Therapy

Endoscopic Dilation Therapy (cont)

Endoscopic Dilation Images

Concluding Remarks

Abbreviations